Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Lilly

Status and phase: Completed; Phase 4

Conditions: Depression

Treatments: Drug: Venlafaxine Extended Release; Drug: Duloxetine Hydrochloride

Study type: Interventional

Funder types: Industry

Identifiers

NCT00071695

6090

F1J-MC-HMBU

Details and patient eligibility

About

How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must be at least 18 years of age
• Must be diagnosed with depression
• Must sign informed consent
• Women who can become pregnant must be using birth control

Exclusion criteria

• Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder
• History of substance abuse or dependence in the last year
• Patients who are suicidal
• Frequent or severe allergic reactions with multiple medications

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind